Carcinogenesis Advance Access published online on November 26, 2008
Carcinogenesis, doi:10.1093/carcin/bgn259
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AMP Kinase Signaling Determines Whether c-Jun N-Terminal Kinase Promotes Survival or Apoptosis during Glucose Deprivation
Department of Biochemistry and Molecular Biology, Medical Research Center for Bioreaction to Reactive Oxygen Species, School of Medicine, Kyung Hee University, Seoul 130-701, Korea
* Corresponding Authors: Wonchae Choe and Joohun Ha, Department of Biochemistry and Molecular Biology, School of Medicine, Kyung Hee University, #1, Hoegi-dong, Dongdaemoon-gu, Seoul 130-701, Korea, Tel: 82-2-961-0940, 82-2-961-0921, Fax: 82-2-959-8168. E-mail: wchoe{at}khu.ac.kr, hajh{at}khu.ac.kr
As solid tumors outgrow the surrounding vasculature, they encounter microenvironments with a limited supply of nutrients. Therefore, in order to survive, tumor cells need to adapt to glucose-deprived environments. In the present study, we examined the signaling pathways that lead to cancer cell survival in response to glucose deprivation. We primarily focused on the roles of AMP-activated protein kinase (AMPK), its upstream kinase LKB1, and c-Jun N-terminal kinase (JNK). Herein, we showed that in DU145 human prostate carcinomas, glucose deprivation activated JNK with biphasic kinetics. We demonstrated that the early phase of JNK activation promoted cell survival, whereas the late phase of JNK activation induced apoptosis. Our data further showed that AMPK relayed a survival signal transmitted by early activation of JNK, and that the sustained AMPK signal in turn inhibited the pro-apoptotic property of JNK via a negative feedback mechanism involving reactive oxygen species. We induced this negative feedback inhibition by expressing LKB1 ectopically in DU145 cells. In conclusion, our results demonstrated how AMPK controls the molecular mechanism underlying the differential biological functions of JNK, and they also provided a novel explanation for the anti-apoptotic role of LKB1.
Received May 30, 2008; revised October 9, 2008; accepted November 1, 2008.